Loading ...

PLA/PLA-PEG/docetaxel nanoparticles

Based on

1 Patents
2014 Most recent source

Composition

1

PLA/PLA-PEG blend

Type Complex Compound
Formula
Role binder
2

1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate}

docetaxel Taxotere Dtxl Doc Dtx
Type Single Compound
Formula C43H53NO14
Role fillers

Properties

Applications

Characterization

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • PLA-PEG
  • 1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate}
  • Lakeshore 100 DL 7E PLA
  1. Xvb0diYQqDoLUZxiZUlVx19uCts5Aa9bFcdjg1fhcn6hy0MG
  2. AozJI2rUjjBF82
Product

PLA/PLA-PEG/docetaxel nanoparticles

Size: 139.8 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial